Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584298 · ClinicalTrials.gov registry record · Phase 1
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
A Phase 1 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT00584298 is a Phase 1 study that has completed, run by Novartis. The registered enrollment target is 50 participants.
The verdict
NCT00584298, a Phase 1 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study is designed to provide information on feasibility and reproducibility of barostat assessments of colorectal sensory functions and compliance and their pharmacological modulation
Interventions
- DRUG Placebo
- DRUG SMS995
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00584298
The ClinicalTrials.gov registry entry for NCT00584298 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00584298 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00584298 about?
NCT00584298 is a clinical study titled "Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide". This study is designed to provide information on feasibility and reproducibility of barostat assessments of colorectal sensory functions and compliance and their pharmacological modulation
What is the current status of trial NCT00584298?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2008-01.
What interventions are being tested in trial NCT00584298?
The interventions under investigation include: Placebo (DRUG), SMS995 (DRUG).
Who is sponsoring clinical trial NCT00584298?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.